Our work
We use molecular biology, animal and human cohort based-studies in combination with proteomics and genetics-based approaches to identify high-density lipoprotein’s (HDL) cardioprotective effects, Lp(a)’s atherogenicity, and the regulation of PCSK9.
Funded by
NIH/NHLBI